Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.870
+0.120 (3.20%)
Oct 13, 2026, 12:39 PM CET

Sprint Bioscience AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
40815511012122191
Market Cap Growth
481.08%40.43%-8.82%449.78%-88.47%17.26%
Enterprise Value
3151447966-5105
Last Close Price
3.751.471.561.710.544.72

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.301.69----
Forward PE
15.405.881.762.4811.062.01
PS Ratio
2.840.931.672.34265.475.45
PB Ratio
4.391.3011.914.360.782.71
P/TBV Ratio
4.391.3011.914.360.782.71
P/FCF Ratio
5.781.86-5.93--
P/OCF Ratio
5.741.86-5.30--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.170.861.191.28-3.01
EV/EBITDA Ratio
3.781.46----
EV/EBIT Ratio
3.831.48----
EV/FCF Ratio
4.421.73-3.24--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.03-1.06-2.70-1.80-1.05-1.00
Net Debt / EBITDA Ratio
-1.17-1.281.4157.000.492.84
Net Debt / FCF Ratio
-1.36-1.521.02-2.450.501.65
Asset Turnover
1.951.871.271.040.000.62
Quick Ratio
7.097.601.141.673.788.74
Current Ratio
7.097.601.141.673.788.74
Return on Equity (ROE)
144.94%142.84%-98.67%-1.57%-122.00%-63.02%
Return on Assets (ROA)
69.03%68.23%-22.46%-1.66%-65.01%-28.29%
Return on Capital Employed (ROCE)
87.60%81.80%-202.40%-4.80%-215.00%-36.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
19.12%59.14%-16.55%-0.36%-273.08%-13.13%
FCF Yield
17.30%53.79%-22.32%16.85%-268.02%-22.41%
Buyback Yield / Dilution
-41.49%-32.63%-0.01%-65.98%-45.85%-71.85%